<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>47</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Elefsiniotis, Loannis S</style></author><author><style face="normal" font="default" size="100%">Dalekos, George N</style></author><author><style face="normal" font="default" size="100%">Koskinas, John</style></author><author><style face="normal" font="default" size="100%">Ioannidou, Panagiota</style></author><author><style face="normal" font="default" size="100%">Cholongitas, Evangelos</style></author><author><style face="normal" font="default" size="100%">Manolakopoulos, Spilios</style></author><author><style face="normal" font="default" size="100%">Goulis, John</style></author><author><style face="normal" font="default" size="100%">Vlachogiannakos, John</style></author><author><style face="normal" font="default" size="100%">Deutsch, Melani</style></author><author><style face="normal" font="default" size="100%">Triantos, Christos K</style></author><author><style face="normal" font="default" size="100%">others</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis</style></title><secondary-title><style face="normal" font="default" size="100%">HEPATOLOGY</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><publisher><style face="normal" font="default" size="100%">WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA</style></publisher><volume><style face="normal" font="default" size="100%">64</style></volume><pages><style face="normal" font="default" size="100%">990A–991A</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>